Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-03-15FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
FDA approved a supplemental application for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited.
-
FDA approval · 2018-03-15FDA Approved: METHOTREXATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Methotrexate submitted by Hospira, Inc.
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
This document reports the completion of a prospective, non-interventional study evaluating tocilizumab (Actemra/RoActemra) in patients with …
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers [Phase 1]
This Phase 1 study reports safety, tolerability, and pharmacokinetics of a single oral dose of SKI-O-703 in healthy volunteers, with rheumat…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28)
A Phase IV study evaluating subcutaneous tocilizumab in rheumatoid arthritis (assessed by DAS28) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing GP2015 to Enbrel in rheumatoid arthritis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: "Learning About Biologics"-Rheumatoid Arthritis [NA]
Completed clinical trial update for rheumatoid arthritis with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy [Phase 4]
Phase 4 trial evaluating adipokines and body composition in rheumatoid arthritis patients treated with tocilizumab.
-
FDA approval · 2018-02-09FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for SIMPONI (golimumab) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2018-02-08Clinical Trial Update: A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis [Phase 3]
A long-term extension study of tocilizumab in early to moderate-to-severe rheumatoid arthritis has terminated with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) [Phase 3]
Phase 3 study evaluating subcutaneous sirukumab (CNTO 136) in active rheumatoid arthritis patients with inadequate response to anti-TNF ther…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial update for BI 695500 in rheumatoid arthritis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA) [Phase 3]
A Phase 3 clinical trial in Japanese patients with active rheumatoid arthritis assessed adding sarilumab to non-MTX DMARDs or as monotherapy…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI) [Phase 3]
Phase 3 study in Japanese patients with moderately to severely active rheumatoid arthritis evaluating added sarilumab to methotrexate; study…
-
CLINICAL_TRIALS trial_result · 2018-01-26Clinical Trial Update: A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial of subcutaneous tocilizumab (RoActemra/Actemra) as monotherapy or with conventional DMARDs in active rheumatoid arthritis comp…
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial update evaluating Acellbia with methotrexate in first-line biological therapy for active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy [Phase 1, Phase 2]
Clinical trial update for GP2013 in rheumatoid arthritis patients refractory to or intolerant of standard therapy, reported results after Ph…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 ) [Phase 3]
Phase 3 clinical trial update on Enerceptan for rheumatoid arthritis, focusing on long-term efficacy, safety, and immunogenicity.
-
FDA approval · 2018-01-23FDA Approved: CELECOXIB — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' generic celecoxib as an Original Application (ANDA210071), enabling market entry for this COX-2 in…
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial of BI 695500 in adults with moderately to severely active rheumatoid arthritis terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: A Moderate to Severe Rheumatoid Arthritis Study [Phase 3]
Phase 3 clinical trial in moderate to severe rheumatoid arthritis completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 trial assessing the effect of puerarin injection on carotid intima-media thickness in patients with rheumatoid arthritis has complet…
-
CLINICAL_TRIALS trial_result · 2018-01-11Clinical Trial Update: A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D) [Phase 3]
A Phase 3 trial evaluating sirukumab (CNTO 136) subcutaneously in active rheumatoid arthritis patients on DMARD therapy has completed with r…
-
CLINICAL_TRIALS research · 2018-01-02Clinical Trial Update: Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study [Phase 1]
A Phase 1 clinical trial update describing a blood sample collection study for pharmacogenomic characterization in participants who previous…
-
FDA approval · 2017-12-29FDA Approved: PIROXICAM — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's Original Application (ANDA) for Piroxicam.